Testosterone Undecanoate Achieves and Maintains Normal Testosterone - Phramalive.com
Testosterone Undecanoate Achieves and Maintains Normal Testosterone - Phramalive.com
Long-term Data Presented at AUA Annual Meeting CHICAGO, April 28 /PRNewswire-FirstCall/ — Endo Pharmaceuticals (NASDAQ: ENDP) today released new long-term clinical trial data in men with hypogonadism who were treated for 21 months with testosterone